Drug Profile


Alternative Names: Balianca; Belara

Latest Information Update: 16 Aug 2010

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Grunenthal
  • Class Alkylated estrogenic steroids; Chlorinated steroids; Hormonal contraceptives; Hormonal replacements; Norpregnatrienes; Oral contraceptives
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Pregnancy
  • No development reported Acne

Most Recent Events

  • 05 Nov 2008 Grunenthal and FAES Farma agree to co-promote ethinylestradiol/chlormadinone in Spain for Contraception/Pregnancy (Prevention)
  • 13 Dec 2007 The Committee for Medicinal Products for Human Use recommends refusal of ethinylestradiol/chlormadinone for acne in women in the EU
  • 30 Jun 2006 Launched for Contraception/Pregnancy (Prevention) in Austria (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top